ALK and anaplastic large cell lymphoma: While gene amplification and point mutations have not been described in driving ALCL nor NSCLC, owing to the absence of wild-type ALK expression, these mechanisms have been described in relation to the fusion proteins as a means of ALK TKI resistance [156,157].